AI steps in to speed up rare blood cancer diagnosis
Knowledge-focused
Completed
This study tested whether artificial intelligence (AI) can help doctors diagnose a rare blood cancer called acute promyelocytic leukemia (APL) more quickly and accurately. Ten doctors reviewed bone marrow samples with and without AI assistance. The goal was to see if AI improves …
Phase: NA • Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC